Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

804
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
804
Inflammatory Response01:28

Inflammatory Response

19.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
19.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

14.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

10.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.8K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

19.5K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
19.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical utility of comprehensive genomic profiling tests using MTB management system at a single center in Japan.

Scientific reports·2026
Same author

Lac-Phe elicits anxiolytic-like effects associated with monoaminergic signaling in mice.

Translational psychiatry·2026
Same author

Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational study.

Journal of gastroenterology·2026
Same author

Coexistence of TP53 and KRAS mutations identifies a molecular subset of biliary tract cancer with poor overall survival after first-line immunochemotherapy.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Fatal retroperitoneal fungal abscess following surgery for gallbladder cancer: an autopsy case report.

Journal of surgical case reports·2026
Same author

Impact of Chronic Constipation and Subtypes on Serum Trimethylamine-N-Oxide Levels and Their Reduction With Treatment: Multicenter Observational Study.

Clinical and translational gastroenterology·2026

Related Experiment Video

Updated: Apr 16, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

27.1K

IL-1 as a target in inflammation.

Yuki Ito, Naoe Kaneko, Tomoyuki Iwasaki

  • 1Department of Pathology Ehime University Proteo-Science Centre and Graduate School of Medicine Shitsukawa 454, Toon, Ehime 791-0295, Japan. masumoto@m.ehime-u.ac.jp.

Endocrine, Metabolic & Immune Disorders Drug Targets
|March 17, 2015
PubMed
Summary

Inflammation is a key defense mechanism, but certain factors can cause tissue damage. This review explores Interleukin-1 (IL-1), a crucial cytokine, as a potential therapeutic target for inflammatory diseases.

More Related Videos

Intravital Imaging of Neutrophil Priming Using IL-1β Promoter-driven DsRed Reporter Mice
09:34

Intravital Imaging of Neutrophil Priming Using IL-1β Promoter-driven DsRed Reporter Mice

Published on: June 22, 2016

10.1K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

27.1K
Intravital Imaging of Neutrophil Priming Using IL-1β Promoter-driven DsRed Reporter Mice
09:34

Intravital Imaging of Neutrophil Priming Using IL-1β Promoter-driven DsRed Reporter Mice

Published on: June 22, 2016

10.1K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.5K

Area of Science:

  • Immunology
  • Pathology

Background:

  • Inflammation is a biological response to harmful stimuli like pathogens or damaged cells.
  • Pathological changes in tissues are often linked to inflammatory processes.
  • Interleukin-1 (IL-1) is an inflammatory cytokine with significant physiological roles.

Purpose of the Study:

  • To review the role of Interleukin-1 (IL-1) in the context of inflammation.
  • To discuss Interleukin-1 (IL-1) as a potential therapeutic target for inflammatory diseases.

Main Methods:

  • Literature review of existing research on inflammation and Interleukin-1.
  • Analysis of the physiological functions and pathological involvement of IL-1.
  • Discussion of IL-1 as a target for therapeutic intervention.

Main Results:

  • Interleukin-1 (IL-1) is implicated in the pathological changes associated with inflammation.
  • IL-1 exhibits diverse physiological functions.
  • Targeting IL-1 presents a promising strategy for managing inflammatory conditions.

Conclusions:

  • Interleukin-1 (IL-1) plays a critical role in both the protective and pathological aspects of inflammation.
  • Modulating IL-1 activity is a viable therapeutic approach for various inflammatory diseases.